UPDATED May 06, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ELABS | kr15.58 | -3.9% | 28.1% | kr1.6b | kr25.00 | PS23.9x | E124.6% | n/a | Software | ||
WAYS | kr22.60 | -2.2% | -53.2% | kr182.4m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
NOHAL | kr22.60 | 5.6% | -11.0% | kr883.8m | kr32.50 | PS8.7x | E56.0% | n/a | Food, Beverage & Tobacco | ||
NEWBRY | kr3.09 | -9.4% | -44.4% | kr75.0m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.44 | -5.8% | 30.3% | kr389.4m | kr2.20 | PS4.3x | E90.4% | n/a | Tech | ||
OSE | €6.33 | 14.7% | 62.1% | €136.5m | €7.15 | PS61.3x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr107.00 | 0.09% | -16.0% | kr5.7b | kr208.00 | PS4.8x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł2.06 | -1.0% | 35.5% | zł72.1m | zł3.71 | PE14.3x | E30.8% | n/a | Diversified Financials | ||
MVW | kr7.90 | -6.5% | 3.4% | kr258.5m | kr13.00 | PS23.5x | E66.8% | n/a | Materials | ||
GWIND | ₺29.48 | 0.6% | 106.0% | ₺15.9b | ₺39.79 | PE25.5x | E60.9% | 1.6% | Utilities | ||
ATAKP | ₺45.58 | -2.6% | n/a | ₺6.3b | ₺67.66 | PE21.4x | E72.8% | n/a | Food, Beverage & Tobacco | ||
AGP | €8.65 | 11.8% | 147.9% | €149.8m | €12.75 | PE30.4x | E22.8% | n/a | Capital Goods | ||
GIG | kr32.90 | -2.2% | 19.6% | kr4.3b | kr49.14 | PE27.2x | E40.7% | n/a | Consumer Services | ||
ELF | US$164.69 | -4.2% | 83.0% | US$9.1b | US$205.92 | PE70.7x | E26.4% | n/a | Household | ||
AXSM | US$75.94 | 3.1% | -2.3% | US$3.6b | US$122.69 | PS14.4x | E63.1% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.80 | 11.4% | 180.7% | US$548.4m | US$11.60 | PS54.9x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$16.51 | 23.9% | -50.1% | US$2.4b | US$31.50 | PE58.1x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.37 | 0.1% | 123.2% | €119.6m | €9.70 | PS19.8x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
FDE | €35.20 | 6.7% | -1.1% | €184.1m | €64.07 | PE23.4x | E37.6% | n/a | Energy | ||
RDUE | €9.65 | 1.6% | 4.9% | €60.3m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
RCEL | US$8.90 | 2.1% | -44.5% | US$229.6m | US$25.90 | PS4.6x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$24.30 | 3.2% | 252.7% | CA$834.2m | CA$24.61 | PE22x | E33.6% | 2.0% | Diversified Financials | ||
AESI | US$22.92 | -1.7% | 34.5% | US$2.5b | US$26.00 | PE23.9x | E45.7% | 3.4% | Energy | ||
ARES | US$136.17 | 0.9% | 66.1% | US$41.7b | US$146.50 | PE61.3x | E41.9% | 2.7% | Diversified Financials |